PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Acetazolamide - Idiopathic Intracranial Hypertension

PAD Profile : Acetazolamide - Idiopathic Intracranial Hypertension

Keywords :
IIH, Carbonic anhydrase inhibitors
Brand Names Include :
Diamox

Traffic Light Status

Status 1 of 1.

Status :
Red
Formulations :
  • Not Specified
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
Comments :
No comments returned.
Documents :

Guidelines

No guidelines returned.

Other Drugs

No drugs returned.

Other Indications

Additional Documents

Committee Recommendations

Date
Committee Name
Narrative
03 November 2021
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands integrated care system Area Prescribing have agreed that acetazolamide should be initiated and prescribed by specialist neurology teams. 

Acetazolamide will be given a RED traffic light status for this indication.
 

Associated BNF Codes

02. Cardiovascular System
02.05.02. Centrally-acting antihypertensive drugs
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
Learn More